Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic adjuvant therapy for breast cancer

E C Reed1

  • 1University of Nebraska Medical Center, Oncology/Hematology, Omaha 68198-3330, USA.

The Nebraska Medical Journal
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NCCN Practice Guidelines for Breast Cancer.

Oncology (Williston Park, N.Y.)·2001
Same author

Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1998
Same author

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.

Bone marrow transplantation·1998
Same author

Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997
Same author

Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.

Bone marrow transplantation·1996
Same author

Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.

Bone marrow transplantation·1996

Adjuvant systemic therapy improves early breast cancer outcomes. Further clinical research is needed to optimize patient selection, treatment regimens, and the use of novel drugs like paclitaxel.

Area of Science:

  • Oncology
  • Clinical Pharmacology

Background:

  • Adjuvant systemic therapy is a cornerstone in early breast cancer management.
  • Established benefits exist, but optimal treatment strategies require further definition.

Purpose of the Study:

  • To highlight existing knowledge gaps in adjuvant systemic therapy for early breast cancer.
  • To emphasize the need for ongoing clinical research to address these questions.

Main Methods:

  • This abstract is a review of current understanding and future research directions.
  • It does not present new experimental data.

Main Results:

  • The benefits of adjuvant systemic therapy are well-documented.
  • Significant questions persist regarding patient and regimen selection, treatment duration, and sequencing.

Related Experiment Videos

Conclusions:

  • Continued participation in well-designed clinical trials is essential.
  • These trials will elucidate the role of high-dose chemotherapy and new agents like paclitaxel.